Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

What is the potential use of platelet-rich-plasma (PRP) in cancer treatment? A mini review

Full text
Author(s):
Luzo, Angela C. M. [1] ; Favaro, Wagner J. [2] ; Seabra, Amedea B. [3] ; Duran, Nelson [2, 3]
Total Authors: 4
Affiliation:
[1] Univ Campinas UNICAMP, Haematol Hemotherapy Ctr, Umbil Cord Blood Bank, Transfus Med Serv, Stem Cell Proc Lab, Campinas - Brazil
[2] Univ Campinas UNICAMP, Dept Struct & Funct Biol, Lab Urogenital Carcinogenesis & Immunotherapy, Campinas, SP - Brazil
[3] Fed Univ ABC UFABC, Ctr Nat & Human Sci CCNH, Nanomed Res Unit Nanomed, Santo Andre, SP - Brazil
Total Affiliations: 3
Document type: Review article
Source: HELIYON; v. 6, n. 3 MAR 2020.
Web of Science Citations: 0
Abstract

Platelet-rich-plasma (PRP) is an autologous human platelet concentrate extracted from plasma. PRP has been investigated in order to be used in many fields, with emphasis on the musculoskeletal field applied to sports injuries, as well as on other medical fields such as cardiac surgery, gynecology, pediatric surgery, urology, ophthalmology and plastic surgery. Cancer treatment is another important field where PRP should be investigated; thus, it is important validating PRP preparation protocols to be used in clinical research. Many protocols should be revised since, overall, most studies do not provide necessary information to allow them to be multiplied or replicated. The current review focuses on several topics about cancer, mainly on innovative studies about PRP use as a feasible therapeutic alternative to treat bladder cancer - a field where it could play a key role. Relevant aspects such as platelets' contribution to immune regulation and the supportive role they play in innate and adaptive immune functions are also addressed. Another important topic reviewed in the current study refers to inflammatory process regulation associated with cancer and thrombosis sites, which indicated that tumor-induced platelet activation could be used as an important therapeutic target in the future. New aspects concerning nitric oxide's ability to restrain platelet adhesion and aggregation in order to slow metastasis progress in cancer patients provide an important advantage in cancer treatment. Finally, the current review has pointed out perspectives and the main concerns about, and possibilities of, PRP use in cancer treatment. (AU)

FAPESP's process: 18/08194-2 - Essential oil amended with metal nanoparticles functionalized with nitric oxide as a strategy to control plant pathogens in the agriculture
Grantee:Amedea Barozzi Seabra
Support Opportunities: Regular Research Grants